StockData
Genenta Science S.p.A. logo

Genenta Science S.p.A. (SAEN) income statement

SAENNasdaqBiological Products, (No Diagnostic Substances)
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.58+0.00 (+0.85%)

Close on Nov 18, 2026Market cap $13.64MP/E –Yield –

Genenta Science S.p.A. income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-38.0%

Financial strength

Current ratio
14.16
Debt to equity
–
Debt to assets
–
Cash to current liabilities
261.0%

Valuation

P/E ratio
–
Price to sales
–
Price to book
0.57
Dividend yield
–

See a number that looks wrong?